Gao et al. [145] found that esophageal cancer (ESC) patient developed irAE including CRS after PD-1 inhibitor therapy and had diarrhea, thrombocytopenia, and multi-organ injury. The gene discussed is PDCD1; the disease is congenital rubella syndrome.